HORSHAM, Pa., Dec. 17, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and ...

After days of real rain, the real wind came and annihilated many trees and cut power for an estimated 300,000 humans in the water-clogged region. “O dark dark dark. They all go into the dark,” howled ...

RYBREVANT FASPRO™, the first and only subcutaneous therapy for patients with EGFR-mutated NSCLC, reduces administration time from hours to minutes and significantly reduces administration-related ...

Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, risk management, and public policy. Peter began covering markets at Multex (Reuters) ...

North Texas is already feeling like winter so far this month, but the traditional start to the season hasn’t quite reached us yet. Here’s when to expect that milestone, as well as a glimpse at the ...

If it weren’t for a Volkswagen bus and a calculator, Apple might never have existed. At the time, the late cofounder Steve Jobs was in his early twenties and strapped for cash, but hooked on the idea ...

This year has been a continuation of learning and understanding about how AI impacts our industry. It’s been less about the chaos of the initial disruption and more about “how do we leverage this?” My ...